Physician profile
Dwight M Jones
NPI 1952675381
$193.72
in general payments reported to CMS, 2019-2025
8 companies · $76.58 in 2025
The $76.58 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $29.53 · 2024: $87.61 · 2025: $76.58.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $194.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $193.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $59.70 | 2025 | Wegovy |
| Glaxosmithkline, LLC. | $30.02 | 2023-2024 | Arexvy, Shingrix |
| Edwards Lifesciences Corporation | $23.40 | 2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Lilly USA, LLC | $18.72 | 2024 | Mounjaro |
| Phathom Pharmaceuticals, INC. | $16.88 | 2025 | Voquezna |
| Amgen INC. | $16.19 | 2024 | Otezla, Repatha |
| Teva Pharmaceuticals USA, INC. | $14.48 | 2023 | Austedo Xr |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $14.33 | 2024 | Caplyta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dwight Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.